Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

BPCE, Novo Banco and Portugal

The Wall Street Journal on MSN · 1d
French Lender Groupe BPCE to Buy Portugal’s Novo Banco for $7.4 Billion
The French retail bank will buy the Portuguese lender from its majority owner Lone Star in the latest cross-border deal in European banking.
Reuters on MSN · 20h
France's BPCE agrees deal to buy Portugal's Novo Banco for $7.4 billion
France’s BPCE has agreed a 6.4 billion euros ($7.39 billion) deal to acquire Portugal's Novo Banco, including a 75% stake held by U.S. private equity firm Lone Star, BPCE and Lone Star said on Friday.
GlobalData on MSN · 1d
BPCE reportedly in talks to acquire Novo Banco
Lone Star Funds owns 75% of Novo Banco, with the Portuguese government holding a 25% stake through various entities.
10don MSN
Novo Banco's shareholders change bylaws for possible IPO, sources say
Shareholders of Portugal's Novo Banco on Wednesday approved key changes to its bylaws that would allow the lender to go ahead ...
3h
Banking’s Mediterranean Deal Flurry Widens With Banco Novo Sale
On Friday, Lone Star agreed to sell its 75% stake in the country’s fourth-largest lender, Novo Banco SA, to the French banking group BPCE SA in what would be the biggest euro area cross-border ...
RTÉ Ireland
1d
Lone Star agrees to sell Portugal's Novo Banco to France's BPCE for €6.4 billion
French banking group BPCE has agreed to buy US private equity fund Lone Star's 75% stake in Novo Banco in a deal that values ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy